肉毒桿菌全球市場(2025-2029)
市場調查報告書
商品編碼
1697288

肉毒桿菌全球市場(2025-2029)

Global Botox Market 2025-2029

出版日期: | 出版商: TechNavio | 英文 208 Pages | 訂單完成後即時交付

價格

預計 2024 年至 2029 年期間肉毒桿菌市場將成長 59.768 億美元,預測期內複合年成長率為 11.2%。

本報告對肉毒桿菌市場、市場規模和預測、趨勢、成長動力、挑戰以及涵蓋約 25 家供應商的供應商分析進行了全面分析。

它提供了對當前市場情景、最新趨勢和促進因素以及整體市場環境的最新分析。推動市場發展的因素包括肉毒桿菌毒素的美容和治療用途不斷增加、對微創治療的需求不斷成長以及肉毒桿菌毒素在牙科中的使用不斷增加等。

市場覆蓋
基準年 2025
年底 2029
預測期 2025-2029
成長動力 加速度
2025與前一年同期比較 9.8%
複合年成長率 11.2%
增量金額 59.768億美元

研究採用客觀結合一手資料和二手資料的方式進行,其中包括來自業界主要參與者的意見。該報告包括全面的市場規模數據(按地理分析細分)和供應商格局以及主要企業的分析。該報告包括歷史和預測數據。

研究指出,醫學美容日益成長的重要性是推動未來幾年肉毒桿菌市場成長的關鍵原因之一。此外,預防性美容療程的需求增加以及男性對臉部護理的需求不斷成長將導致市場需求大幅增加。

目錄

第1章執行摘要

  • 市場概覽

第2章 Technavio 分析

  • 價格、生命週期、顧客購買籃、採用率和購買標準的分析
  • 投入與差異化因素的重要性
  • 混亂的根源
  • 促進因素和挑戰的影響

第3章 市場狀況

  • 市場生態系統
  • 市場特徵
  • 價值鏈分析

第4章 市場規模

  • 市場定義
  • 市場區隔分析
  • 2024年市場規模
  • 2024-2029年市場展望

第5章 市場規模表現

  • 2019-2023年全球肉毒桿菌市場
  • 2019-2023年應用細分分析
  • 2019-2023年最終用戶細分分析
  • 2019-2023年性別細分分析
  • 2019-2023年區域細分分析
  • 2019-2023年國家細分分析

第6章定性分析

  • 人工智慧的影響:全球肉毒桿菌市場

第7章五力分析

  • 五力模型摘要
  • 買家的議價能力
  • 供應商的議價能力
  • 新進入者的威脅
  • 替代品的威脅
  • 競爭威脅
  • 市場狀況

第 8 章按應用分類的市場區隔

  • 市場區隔
  • 比較:按應用
  • 美的:2024-2029年市場規模及預測
  • 醫療保健:2024-2029 年市場規模及預測
  • 按應用分類的市場機會

第9章依最終用戶細分市場

  • 市場區隔
  • 比較:按最終用戶
  • 醫院:2024-2029 年市場規模及預測
  • 皮膚科診所:市場規模及預測(2024-2029)
  • 其他:2024-2029 年市場規模及預測
  • 最終用戶的市場機會

第10章 按性別分類的市場區隔

  • 市場區隔
  • 比較:性別
  • 女性:2024-2029 年市場規模及預測
  • 男性:2024-2029 年市場規模及預測
  • 市場機會:性別

第11章 客戶情況

  • 客戶概覽

第12章 地區情勢

  • 地理細分
  • 區域比較
  • 北美:2024-2029 年市場規模及預測
  • 歐洲:2024-2029 年市場規模及預測
  • 亞洲:2024-2029 年市場規模及預測
  • 世界其他地區:2024-2029 年市場規模及預測
  • 美國:市場規模及預測(2024-2029)
  • 墨西哥:2024-2029 年市場規模及預測
  • 巴西:2024-2029 年市場規模及預測
  • 日本:2024-2029 年市場規模及預測
  • 德國:2024-2029年市場規模及預測
  • 英國:2024-2029 年市場規模及預測
  • 加拿大:2024-2029 年市場規模及預測
  • 中國:2024-2029年市場規模及預測
  • 南非:2024-2029 年市場規模及預測
  • 印度:2024-2029 年市場規模及預測
  • 按地區分類的市場機會

第13章 促進因素、挑戰、機會與限制因素

  • 市場促進因素
  • 市場挑戰
  • 促進因素和挑戰的影響
  • 市場機會與限制

第14章競爭格局

  • 概述
  • 競爭格局
  • 令人困惑的情況
  • 產業風險

第15章 競爭分析

  • 公司簡介
  • 企業排名指數
  • 公司市場定位
  • AbbVie Inc.
  • BTXA
  • Daewoong Bio Inc.
  • Evolus Inc.
  • FASTOX Pharma
  • Galderma SA
  • Hugel Inc.
  • Huons Global
  • Ipsen Pharma
  • Medytox
  • Merz Pharma GmbH and Co. KGaA
  • NEXUS LIFECARE PVT. LTD.
  • Object Pharma Inc.
  • Revance Therapeutics Inc.
  • SciVision Biotech Inc.

第16章 附錄

Product Code: IRTNTR71048

The botox market is forecasted to grow by USD 5976.8 mn during 2024-2029, accelerating at a CAGR of 11.2% during the forecast period. The report on the botox market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasing applications of botox in cosmetic and therapeutic procedures, rising demand for minimally invasive procedures, and increasing use of botox in dentistry.

Market Scope
Base Year2025
End Year2029
Series Year2025-2029
Growth MomentumAccelerate
YOY 20259.8%
CAGR11.2%
Incremental Value$5976.8 mn

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.

Technavio's botox market is segmented as below:

By Application

    • Aesthetic
    • Medical

By End-user

    • Hospitals
    • Dermatology clinics
    • Others

By Gender

    • Female
    • Male

By Geographical Landscape

    • North America
    • Europe
    • Asia
    • Rest of World (ROW)

This study identifies the growing importance of medical aesthetics as one of the prime reasons driving the botox market growth during the next few years. Also, increasing demand for preventive cosmetic treatments and growing demand from men for facial aesthetics will lead to sizable demand in the market.

The report on the botox market covers the following areas:

    • Botox Market sizing
    • Botox Market forecast
    • Botox Market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading botox market vendors that include AbbVie Inc., Bausch Health Companies Inc., BTXA, Candela Corp., Daewoong Bio Inc., Eisai Co. Ltd., Evolus Inc., FASTOX Pharma, Galderma SA, Hugel Inc., Huons Global, Ipsen Pharma, Medytox, Merz Pharma GmbH and Co. KGaA, NEXUS LIFECARE PVT. LTD., Object Pharma Inc., Revance Therapeutics Inc., and SciVision Biotech Inc.. Also, the botox market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Table of Contents

1 Executive Summary

  • 1.1 Market overview
    • Executive Summary - Chart on Market Overview
    • Executive Summary - Data Table on Market Overview
    • Executive Summary - Chart on Global Market Characteristics
    • Executive Summary - Chart on Market By Geographical Landscape
    • Executive Summary - Chart on Market Segmentation by Application
    • Executive Summary - Chart on Market Segmentation by End-user
    • Executive Summary - Chart on Market Segmentation by Gender
    • Executive Summary - Chart on Incremental Growth
    • Executive Summary - Data Table on Incremental Growth
    • Executive Summary - Chart on Company Market Positioning

2 Technavio Analysis

  • 2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
    • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
  • 2.2 Criticality of inputs and Factors of differentiation
    • Overview on criticality of inputs and factors of differentiation
  • 2.3 Factors of disruption
    • Overview on factors of disruption
  • 2.4 Impact of drivers and challenges
    • Impact of drivers and challenges in 2024 and 2029

3 Market Landscape

  • 3.1 Market ecosystem
    • Parent Market
    • Data Table on - Parent Market
  • 3.2 Market characteristics
    • Market characteristics analysis
  • 3.3 Value chain analysis
    • Value chain analysis

4 Market Sizing

  • 4.1 Market definition
    • Offerings of companies included in the market definition
  • 4.2 Market segment analysis
    • Market segments
  • 4.3 Market size 2024
  • 4.4 Market outlook: Forecast for 2024-2029
    • Chart on Global - Market size and forecast 2024-2029 ($ million)
    • Data Table on Global - Market size and forecast 2024-2029 ($ million)
    • Chart on Global Market: Year-over-year growth 2024-2029 (%)
    • Data Table on Global Market: Year-over-year growth 2024-2029 (%)

5 Historic Market Size

  • 5.1 Global Botox Market 2019 - 2023
    • Historic Market Size - Data Table on Global Botox Market 2019 - 2023 ($ million)
  • 5.2 Application segment analysis 2019 - 2023
    • Historic Market Size - Application Segment 2019 - 2023 ($ million)
  • 5.3 End-user segment analysis 2019 - 2023
    • Historic Market Size - End-user Segment 2019 - 2023 ($ million)
  • 5.4 Gender segment analysis 2019 - 2023
    • Historic Market Size - Gender Segment 2019 - 2023 ($ million)
  • 5.5 Geography segment analysis 2019 - 2023
    • Historic Market Size - Geography Segment 2019 - 2023 ($ million)
  • 5.6 Country segment analysis 2019 - 2023
    • Historic Market Size - Country Segment 2019 - 2023 ($ million)

6 Qualitative Analysis

  • 6.1 Impact of AI on Global Botox Market

7 Five Forces Analysis

  • 7.1 Five forces summary
    • Five forces analysis - Comparison between 2024 and 2029
  • 7.2 Bargaining power of buyers
    • Bargaining power of buyers - Impact of key factors 2024 and 2029
  • 7.3 Bargaining power of suppliers
    • Bargaining power of suppliers - Impact of key factors in 2024 and 2029
  • 7.4 Threat of new entrants
    • Threat of new entrants - Impact of key factors in 2024 and 2029
  • 7.5 Threat of substitutes
    • Threat of substitutes - Impact of key factors in 2024 and 2029
  • 7.6 Threat of rivalry
    • Threat of rivalry - Impact of key factors in 2024 and 2029
  • 7.7 Market condition
    • Chart on Market condition - Five forces 2024 and 2029

8 Market Segmentation by Application

  • 8.1 Market segments
    • Chart on Application - Market share 2024-2029 (%)
    • Data Table on Application - Market share 2024-2029 (%)
  • 8.2 Comparison by Application
    • Chart on Comparison by Application
    • Data Table on Comparison by Application
  • 8.3 Aesthetic - Market size and forecast 2024-2029
    • Chart on Aesthetic - Market size and forecast 2024-2029 ($ million)
    • Data Table on Aesthetic - Market size and forecast 2024-2029 ($ million)
    • Chart on Aesthetic - Year-over-year growth 2024-2029 (%)
    • Data Table on Aesthetic - Year-over-year growth 2024-2029 (%)
  • 8.4 Medical - Market size and forecast 2024-2029
    • Chart on Medical - Market size and forecast 2024-2029 ($ million)
    • Data Table on Medical - Market size and forecast 2024-2029 ($ million)
    • Chart on Medical - Year-over-year growth 2024-2029 (%)
    • Data Table on Medical - Year-over-year growth 2024-2029 (%)
  • 8.5 Market opportunity by Application
    • Market opportunity by Application ($ million)
    • Data Table on Market opportunity by Application ($ million)

9 Market Segmentation by End-user

  • 9.1 Market segments
    • Chart on End-user - Market share 2024-2029 (%)
    • Data Table on End-user - Market share 2024-2029 (%)
  • 9.2 Comparison by End-user
    • Chart on Comparison by End-user
    • Data Table on Comparison by End-user
  • 9.3 Hospitals - Market size and forecast 2024-2029
    • Chart on Hospitals - Market size and forecast 2024-2029 ($ million)
    • Data Table on Hospitals - Market size and forecast 2024-2029 ($ million)
    • Chart on Hospitals - Year-over-year growth 2024-2029 (%)
    • Data Table on Hospitals - Year-over-year growth 2024-2029 (%)
  • 9.4 Dermatology clinics - Market size and forecast 2024-2029
    • Chart on Dermatology clinics - Market size and forecast 2024-2029 ($ million)
    • Data Table on Dermatology clinics - Market size and forecast 2024-2029 ($ million)
    • Chart on Dermatology clinics - Year-over-year growth 2024-2029 (%)
    • Data Table on Dermatology clinics - Year-over-year growth 2024-2029 (%)
  • 9.5 Others - Market size and forecast 2024-2029
    • Chart on Others - Market size and forecast 2024-2029 ($ million)
    • Data Table on Others - Market size and forecast 2024-2029 ($ million)
    • Chart on Others - Year-over-year growth 2024-2029 (%)
    • Data Table on Others - Year-over-year growth 2024-2029 (%)
  • 9.6 Market opportunity by End-user
    • Market opportunity by End-user ($ million)
    • Data Table on Market opportunity by End-user ($ million)

10 Market Segmentation by Gender

  • 10.1 Market segments
    • Chart on Gender - Market share 2024-2029 (%)
    • Data Table on Gender - Market share 2024-2029 (%)
  • 10.2 Comparison by Gender
    • Chart on Comparison by Gender
    • Data Table on Comparison by Gender
  • 10.3 Female - Market size and forecast 2024-2029
    • Chart on Female - Market size and forecast 2024-2029 ($ million)
    • Data Table on Female - Market size and forecast 2024-2029 ($ million)
    • Chart on Female - Year-over-year growth 2024-2029 (%)
    • Data Table on Female - Year-over-year growth 2024-2029 (%)
  • 10.4 Male - Market size and forecast 2024-2029
    • Chart on Male - Market size and forecast 2024-2029 ($ million)
    • Data Table on Male - Market size and forecast 2024-2029 ($ million)
    • Chart on Male - Year-over-year growth 2024-2029 (%)
    • Data Table on Male - Year-over-year growth 2024-2029 (%)
  • 10.5 Market opportunity by Gender
    • Market opportunity by Gender ($ million)
    • Data Table on Market opportunity by Gender ($ million)

11 Customer Landscape

  • 11.1 Customer landscape overview
    • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

12 Geographic Landscape

  • 12.1 Geographic segmentation
    • Chart on Market share By Geographical Landscape 2024-2029 (%)
    • Data Table on Market share By Geographical Landscape 2024-2029 (%)
  • 12.2 Geographic comparison
    • Chart on Geographic comparison
    • Data Table on Geographic comparison
  • 12.3 North America - Market size and forecast 2024-2029
    • Chart on North America - Market size and forecast 2024-2029 ($ million)
    • Data Table on North America - Market size and forecast 2024-2029 ($ million)
    • Chart on North America - Year-over-year growth 2024-2029 (%)
    • Data Table on North America - Year-over-year growth 2024-2029 (%)
  • 12.4 Europe - Market size and forecast 2024-2029
    • Chart on Europe - Market size and forecast 2024-2029 ($ million)
    • Data Table on Europe - Market size and forecast 2024-2029 ($ million)
    • Chart on Europe - Year-over-year growth 2024-2029 (%)
    • Data Table on Europe - Year-over-year growth 2024-2029 (%)
  • 12.5 Asia - Market size and forecast 2024-2029
    • Chart on Asia - Market size and forecast 2024-2029 ($ million)
    • Data Table on Asia - Market size and forecast 2024-2029 ($ million)
    • Chart on Asia - Year-over-year growth 2024-2029 (%)
    • Data Table on Asia - Year-over-year growth 2024-2029 (%)
  • 12.6 Rest of World (ROW) - Market size and forecast 2024-2029
    • Chart on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
    • Data Table on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
    • Chart on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
    • Data Table on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
  • 12.7 US - Market size and forecast 2024-2029
    • Chart on US - Market size and forecast 2024-2029 ($ million)
    • Data Table on US - Market size and forecast 2024-2029 ($ million)
    • Chart on US - Year-over-year growth 2024-2029 (%)
    • Data Table on US - Year-over-year growth 2024-2029 (%)
  • 12.8 Mexico - Market size and forecast 2024-2029
    • Chart on Mexico - Market size and forecast 2024-2029 ($ million)
    • Data Table on Mexico - Market size and forecast 2024-2029 ($ million)
    • Chart on Mexico - Year-over-year growth 2024-2029 (%)
    • Data Table on Mexico - Year-over-year growth 2024-2029 (%)
  • 12.9 Brazil - Market size and forecast 2024-2029
    • Chart on Brazil - Market size and forecast 2024-2029 ($ million)
    • Data Table on Brazil - Market size and forecast 2024-2029 ($ million)
    • Chart on Brazil - Year-over-year growth 2024-2029 (%)
    • Data Table on Brazil - Year-over-year growth 2024-2029 (%)
  • 12.10 Japan - Market size and forecast 2024-2029
    • Chart on Japan - Market size and forecast 2024-2029 ($ million)
    • Data Table on Japan - Market size and forecast 2024-2029 ($ million)
    • Chart on Japan - Year-over-year growth 2024-2029 (%)
    • Data Table on Japan - Year-over-year growth 2024-2029 (%)
  • 12.11 Germany - Market size and forecast 2024-2029
    • Chart on Germany - Market size and forecast 2024-2029 ($ million)
    • Data Table on Germany - Market size and forecast 2024-2029 ($ million)
    • Chart on Germany - Year-over-year growth 2024-2029 (%)
    • Data Table on Germany - Year-over-year growth 2024-2029 (%)
  • 12.12 UK - Market size and forecast 2024-2029
    • Chart on UK - Market size and forecast 2024-2029 ($ million)
    • Data Table on UK - Market size and forecast 2024-2029 ($ million)
    • Chart on UK - Year-over-year growth 2024-2029 (%)
    • Data Table on UK - Year-over-year growth 2024-2029 (%)
  • 12.13 Canada - Market size and forecast 2024-2029
    • Chart on Canada - Market size and forecast 2024-2029 ($ million)
    • Data Table on Canada - Market size and forecast 2024-2029 ($ million)
    • Chart on Canada - Year-over-year growth 2024-2029 (%)
    • Data Table on Canada - Year-over-year growth 2024-2029 (%)
  • 12.14 China - Market size and forecast 2024-2029
    • Chart on China - Market size and forecast 2024-2029 ($ million)
    • Data Table on China - Market size and forecast 2024-2029 ($ million)
    • Chart on China - Year-over-year growth 2024-2029 (%)
    • Data Table on China - Year-over-year growth 2024-2029 (%)
  • 12.15 South Africa - Market size and forecast 2024-2029
    • Chart on South Africa - Market size and forecast 2024-2029 ($ million)
    • Data Table on South Africa - Market size and forecast 2024-2029 ($ million)
    • Chart on South Africa - Year-over-year growth 2024-2029 (%)
    • Data Table on South Africa - Year-over-year growth 2024-2029 (%)
  • 12.16 India - Market size and forecast 2024-2029
    • Chart on India - Market size and forecast 2024-2029 ($ million)
    • Data Table on India - Market size and forecast 2024-2029 ($ million)
    • Chart on India - Year-over-year growth 2024-2029 (%)
    • Data Table on India - Year-over-year growth 2024-2029 (%)
  • 12.17 Market opportunity By Geographical Landscape
    • Market opportunity By Geographical Landscape ($ million)
    • Data Tables on Market opportunity By Geographical Landscape ($ million)

13 Drivers, Challenges, and Opportunity/Restraints

  • 13.1 Market drivers
  • 13.2 Market challenges
  • 13.3 Impact of drivers and challenges
    • Impact of drivers and challenges in 2024 and 2029
  • 13.4 Market opportunities/restraints

14 Competitive Landscape

  • 14.1 Overview
  • 14.2 Competitive Landscape
    • Overview on criticality of inputs and factors of differentiation
  • 14.3 Landscape disruption
    • Overview on factors of disruption
  • 14.4 Industry risks
    • Impact of key risks on business

15 Competitive Analysis

  • 15.1 Companies profiled
    • Companies covered
  • 15.2 Company ranking index
    • Company ranking index
  • 15.3 Market positioning of companies
    • Matrix on companies position and classification
  • 15.4 AbbVie Inc.
    • AbbVie Inc. - Overview
    • AbbVie Inc. - Product / Service
    • AbbVie Inc. - Key news
    • AbbVie Inc. - Key offerings
    • SWOT
  • 15.5 BTXA
    • BTXA - Overview
    • BTXA - Product / Service
    • BTXA - Key offerings
    • SWOT
  • 15.6 Daewoong Bio Inc.
    • Daewoong Bio Inc. - Overview
    • Daewoong Bio Inc. - Product / Service
    • Daewoong Bio Inc. - Key offerings
    • SWOT
  • 15.7 Evolus Inc.
    • Evolus Inc. - Overview
    • Evolus Inc. - Product / Service
    • Evolus Inc. - Key offerings
    • SWOT
  • 15.8 FASTOX Pharma
    • FASTOX Pharma - Overview
    • FASTOX Pharma - Product / Service
    • FASTOX Pharma - Key offerings
    • SWOT
  • 15.9 Galderma SA
    • Galderma SA - Overview
    • Galderma SA - Product / Service
    • Galderma SA - Key offerings
    • SWOT
  • 15.10 Hugel Inc.
    • Hugel Inc. - Overview
    • Hugel Inc. - Product / Service
    • Hugel Inc. - Key offerings
    • SWOT
  • 15.11 Huons Global
    • Huons Global - Overview
    • Huons Global - Product / Service
    • Huons Global - Key offerings
    • SWOT
  • 15.12 Ipsen Pharma
    • Ipsen Pharma - Overview
    • Ipsen Pharma - Business segments
    • Ipsen Pharma - Key offerings
    • Ipsen Pharma - Segment focus
    • SWOT
  • 15.13 Medytox
    • Medytox - Overview
    • Medytox - Product / Service
    • Medytox - Key offerings
    • SWOT
  • 15.14 Merz Pharma GmbH and Co. KGaA
    • Merz Pharma GmbH and Co. KGaA - Overview
    • Merz Pharma GmbH and Co. KGaA - Product / Service
    • Merz Pharma GmbH and Co. KGaA - Key offerings
    • SWOT
  • 15.15 NEXUS LIFECARE PVT. LTD.
    • NEXUS LIFECARE PVT. LTD. - Overview
    • NEXUS LIFECARE PVT. LTD. - Product / Service
    • NEXUS LIFECARE PVT. LTD. - Key offerings
    • SWOT
  • 15.16 Object Pharma Inc.
    • Object Pharma Inc. - Overview
    • Object Pharma Inc. - Product / Service
    • Object Pharma Inc. - Key offerings
    • SWOT
  • 15.17 Revance Therapeutics Inc.
    • Revance Therapeutics Inc. - Overview
    • Revance Therapeutics Inc. - Product / Service
    • Revance Therapeutics Inc. - Key offerings
    • SWOT
  • 15.18 SciVision Biotech Inc.
    • SciVision Biotech Inc. - Overview
    • SciVision Biotech Inc. - Product / Service
    • SciVision Biotech Inc. - Key offerings
    • SWOT

16 Appendix

  • 16.1 Scope of the report
  • 16.2 Inclusions and exclusions checklist
    • Inclusions checklist
    • Exclusions checklist
  • 16.3 Currency conversion rates for US$
    • Currency conversion rates for US$
  • 16.4 Research methodology
    • Research methodology
  • 16.5 Data procurement
    • Information sources
  • 16.6 Data validation
    • Data validation
  • 16.7 Validation techniques employed for market sizing
    • Validation techniques employed for market sizing
  • 16.8 Data synthesis
    • Data synthesis
  • 16.9 360 degree market analysis
    • 360 degree market analysis
  • 16.10 List of abbreviations
    • List of abbreviations

Exhibits:

  • Exhibits1: Executive Summary - Chart on Market Overview
  • Exhibits2: Executive Summary - Data Table on Market Overview
  • Exhibits3: Executive Summary - Chart on Global Market Characteristics
  • Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
  • Exhibits5: Executive Summary - Chart on Market Segmentation by Application
  • Exhibits6: Executive Summary - Chart on Market Segmentation by End-user
  • Exhibits7: Executive Summary - Chart on Market Segmentation by Gender
  • Exhibits8: Executive Summary - Chart on Incremental Growth
  • Exhibits9: Executive Summary - Data Table on Incremental Growth
  • Exhibits10: Executive Summary - Chart on Company Market Positioning
  • Exhibits11: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
  • Exhibits12: Overview on criticality of inputs and factors of differentiation
  • Exhibits13: Overview on factors of disruption
  • Exhibits14: Impact of drivers and challenges in 2024 and 2029
  • Exhibits15: Parent Market
  • Exhibits16: Data Table on - Parent Market
  • Exhibits17: Market characteristics analysis
  • Exhibits18: Value chain analysis
  • Exhibits19: Offerings of companies included in the market definition
  • Exhibits20: Market segments
  • Exhibits21: Chart on Global - Market size and forecast 2024-2029 ($ million)
  • Exhibits22: Data Table on Global - Market size and forecast 2024-2029 ($ million)
  • Exhibits23: Chart on Global Market: Year-over-year growth 2024-2029 (%)
  • Exhibits24: Data Table on Global Market: Year-over-year growth 2024-2029 (%)
  • Exhibits25: Historic Market Size - Data Table on Global Botox Market 2019 - 2023 ($ million)
  • Exhibits26: Historic Market Size - Application Segment 2019 - 2023 ($ million)
  • Exhibits27: Historic Market Size - End-user Segment 2019 - 2023 ($ million)
  • Exhibits28: Historic Market Size - Gender Segment 2019 - 2023 ($ million)
  • Exhibits29: Historic Market Size - Geography Segment 2019 - 2023 ($ million)
  • Exhibits30: Historic Market Size - Country Segment 2019 - 2023 ($ million)
  • Exhibits31: Five forces analysis - Comparison between 2024 and 2029
  • Exhibits32: Bargaining power of buyers - Impact of key factors 2024 and 2029
  • Exhibits33: Bargaining power of suppliers - Impact of key factors in 2024 and 2029
  • Exhibits34: Threat of new entrants - Impact of key factors in 2024 and 2029
  • Exhibits35: Threat of substitutes - Impact of key factors in 2024 and 2029
  • Exhibits36: Threat of rivalry - Impact of key factors in 2024 and 2029
  • Exhibits37: Chart on Market condition - Five forces 2024 and 2029
  • Exhibits38: Chart on Application - Market share 2024-2029 (%)
  • Exhibits39: Data Table on Application - Market share 2024-2029 (%)
  • Exhibits40: Chart on Comparison by Application
  • Exhibits41: Data Table on Comparison by Application
  • Exhibits42: Chart on Aesthetic - Market size and forecast 2024-2029 ($ million)
  • Exhibits43: Data Table on Aesthetic - Market size and forecast 2024-2029 ($ million)
  • Exhibits44: Chart on Aesthetic - Year-over-year growth 2024-2029 (%)
  • Exhibits45: Data Table on Aesthetic - Year-over-year growth 2024-2029 (%)
  • Exhibits46: Chart on Medical - Market size and forecast 2024-2029 ($ million)
  • Exhibits47: Data Table on Medical - Market size and forecast 2024-2029 ($ million)
  • Exhibits48: Chart on Medical - Year-over-year growth 2024-2029 (%)
  • Exhibits49: Data Table on Medical - Year-over-year growth 2024-2029 (%)
  • Exhibits50: Market opportunity by Application ($ million)
  • Exhibits51: Data Table on Market opportunity by Application ($ million)
  • Exhibits52: Chart on End-user - Market share 2024-2029 (%)
  • Exhibits53: Data Table on End-user - Market share 2024-2029 (%)
  • Exhibits54: Chart on Comparison by End-user
  • Exhibits55: Data Table on Comparison by End-user
  • Exhibits56: Chart on Hospitals - Market size and forecast 2024-2029 ($ million)
  • Exhibits57: Data Table on Hospitals - Market size and forecast 2024-2029 ($ million)
  • Exhibits58: Chart on Hospitals - Year-over-year growth 2024-2029 (%)
  • Exhibits59: Data Table on Hospitals - Year-over-year growth 2024-2029 (%)
  • Exhibits60: Chart on Dermatology clinics - Market size and forecast 2024-2029 ($ million)
  • Exhibits61: Data Table on Dermatology clinics - Market size and forecast 2024-2029 ($ million)
  • Exhibits62: Chart on Dermatology clinics - Year-over-year growth 2024-2029 (%)
  • Exhibits63: Data Table on Dermatology clinics - Year-over-year growth 2024-2029 (%)
  • Exhibits64: Chart on Others - Market size and forecast 2024-2029 ($ million)
  • Exhibits65: Data Table on Others - Market size and forecast 2024-2029 ($ million)
  • Exhibits66: Chart on Others - Year-over-year growth 2024-2029 (%)
  • Exhibits67: Data Table on Others - Year-over-year growth 2024-2029 (%)
  • Exhibits68: Market opportunity by End-user ($ million)
  • Exhibits69: Data Table on Market opportunity by End-user ($ million)
  • Exhibits70: Chart on Gender - Market share 2024-2029 (%)
  • Exhibits71: Data Table on Gender - Market share 2024-2029 (%)
  • Exhibits72: Chart on Comparison by Gender
  • Exhibits73: Data Table on Comparison by Gender
  • Exhibits74: Chart on Female - Market size and forecast 2024-2029 ($ million)
  • Exhibits75: Data Table on Female - Market size and forecast 2024-2029 ($ million)
  • Exhibits76: Chart on Female - Year-over-year growth 2024-2029 (%)
  • Exhibits77: Data Table on Female - Year-over-year growth 2024-2029 (%)
  • Exhibits78: Chart on Male - Market size and forecast 2024-2029 ($ million)
  • Exhibits79: Data Table on Male - Market size and forecast 2024-2029 ($ million)
  • Exhibits80: Chart on Male - Year-over-year growth 2024-2029 (%)
  • Exhibits81: Data Table on Male - Year-over-year growth 2024-2029 (%)
  • Exhibits82: Market opportunity by Gender ($ million)
  • Exhibits83: Data Table on Market opportunity by Gender ($ million)
  • Exhibits84: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
  • Exhibits85: Chart on Market share By Geographical Landscape 2024-2029 (%)
  • Exhibits86: Data Table on Market share By Geographical Landscape 2024-2029 (%)
  • Exhibits87: Chart on Geographic comparison
  • Exhibits88: Data Table on Geographic comparison
  • Exhibits89: Chart on North America - Market size and forecast 2024-2029 ($ million)
  • Exhibits90: Data Table on North America - Market size and forecast 2024-2029 ($ million)
  • Exhibits91: Chart on North America - Year-over-year growth 2024-2029 (%)
  • Exhibits92: Data Table on North America - Year-over-year growth 2024-2029 (%)
  • Exhibits93: Chart on Europe - Market size and forecast 2024-2029 ($ million)
  • Exhibits94: Data Table on Europe - Market size and forecast 2024-2029 ($ million)
  • Exhibits95: Chart on Europe - Year-over-year growth 2024-2029 (%)
  • Exhibits96: Data Table on Europe - Year-over-year growth 2024-2029 (%)
  • Exhibits97: Chart on Asia - Market size and forecast 2024-2029 ($ million)
  • Exhibits98: Data Table on Asia - Market size and forecast 2024-2029 ($ million)
  • Exhibits99: Chart on Asia - Year-over-year growth 2024-2029 (%)
  • Exhibits100: Data Table on Asia - Year-over-year growth 2024-2029 (%)
  • Exhibits101: Chart on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
  • Exhibits102: Data Table on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
  • Exhibits103: Chart on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
  • Exhibits104: Data Table on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
  • Exhibits105: Chart on US - Market size and forecast 2024-2029 ($ million)
  • Exhibits106: Data Table on US - Market size and forecast 2024-2029 ($ million)
  • Exhibits107: Chart on US - Year-over-year growth 2024-2029 (%)
  • Exhibits108: Data Table on US - Year-over-year growth 2024-2029 (%)
  • Exhibits109: Chart on Mexico - Market size and forecast 2024-2029 ($ million)
  • Exhibits110: Data Table on Mexico - Market size and forecast 2024-2029 ($ million)
  • Exhibits111: Chart on Mexico - Year-over-year growth 2024-2029 (%)
  • Exhibits112: Data Table on Mexico - Year-over-year growth 2024-2029 (%)
  • Exhibits113: Chart on Brazil - Market size and forecast 2024-2029 ($ million)
  • Exhibits114: Data Table on Brazil - Market size and forecast 2024-2029 ($ million)
  • Exhibits115: Chart on Brazil - Year-over-year growth 2024-2029 (%)
  • Exhibits116: Data Table on Brazil - Year-over-year growth 2024-2029 (%)
  • Exhibits117: Chart on Japan - Market size and forecast 2024-2029 ($ million)
  • Exhibits118: Data Table on Japan - Market size and forecast 2024-2029 ($ million)
  • Exhibits119: Chart on Japan - Year-over-year growth 2024-2029 (%)
  • Exhibits120: Data Table on Japan - Year-over-year growth 2024-2029 (%)
  • Exhibits121: Chart on Germany - Market size and forecast 2024-2029 ($ million)
  • Exhibits122: Data Table on Germany - Market size and forecast 2024-2029 ($ million)
  • Exhibits123: Chart on Germany - Year-over-year growth 2024-2029 (%)
  • Exhibits124: Data Table on Germany - Year-over-year growth 2024-2029 (%)
  • Exhibits125: Chart on UK - Market size and forecast 2024-2029 ($ million)
  • Exhibits126: Data Table on UK - Market size and forecast 2024-2029 ($ million)
  • Exhibits127: Chart on UK - Year-over-year growth 2024-2029 (%)
  • Exhibits128: Data Table on UK - Year-over-year growth 2024-2029 (%)
  • Exhibits129: Chart on Canada - Market size and forecast 2024-2029 ($ million)
  • Exhibits130: Data Table on Canada - Market size and forecast 2024-2029 ($ million)
  • Exhibits131: Chart on Canada - Year-over-year growth 2024-2029 (%)
  • Exhibits132: Data Table on Canada - Year-over-year growth 2024-2029 (%)
  • Exhibits133: Chart on China - Market size and forecast 2024-2029 ($ million)
  • Exhibits134: Data Table on China - Market size and forecast 2024-2029 ($ million)
  • Exhibits135: Chart on China - Year-over-year growth 2024-2029 (%)
  • Exhibits136: Data Table on China - Year-over-year growth 2024-2029 (%)
  • Exhibits137: Chart on South Africa - Market size and forecast 2024-2029 ($ million)
  • Exhibits138: Data Table on South Africa - Market size and forecast 2024-2029 ($ million)
  • Exhibits139: Chart on South Africa - Year-over-year growth 2024-2029 (%)
  • Exhibits140: Data Table on South Africa - Year-over-year growth 2024-2029 (%)
  • Exhibits141: Chart on India - Market size and forecast 2024-2029 ($ million)
  • Exhibits142: Data Table on India - Market size and forecast 2024-2029 ($ million)
  • Exhibits143: Chart on India - Year-over-year growth 2024-2029 (%)
  • Exhibits144: Data Table on India - Year-over-year growth 2024-2029 (%)
  • Exhibits145: Market opportunity By Geographical Landscape ($ million)
  • Exhibits146: Data Tables on Market opportunity By Geographical Landscape ($ million)
  • Exhibits147: Impact of drivers and challenges in 2024 and 2029
  • Exhibits148: Overview on criticality of inputs and factors of differentiation
  • Exhibits149: Overview on factors of disruption
  • Exhibits150: Impact of key risks on business
  • Exhibits151: Companies covered
  • Exhibits152: Company ranking index
  • Exhibits153: Matrix on companies position and classification
  • Exhibits154: AbbVie Inc. - Overview
  • Exhibits155: AbbVie Inc. - Product / Service
  • Exhibits156: AbbVie Inc. - Key news
  • Exhibits157: AbbVie Inc. - Key offerings
  • Exhibits158: SWOT
  • Exhibits159: BTXA - Overview
  • Exhibits160: BTXA - Product / Service
  • Exhibits161: BTXA - Key offerings
  • Exhibits162: SWOT
  • Exhibits163: Daewoong Bio Inc. - Overview
  • Exhibits164: Daewoong Bio Inc. - Product / Service
  • Exhibits165: Daewoong Bio Inc. - Key offerings
  • Exhibits166: SWOT
  • Exhibits167: Evolus Inc. - Overview
  • Exhibits168: Evolus Inc. - Product / Service
  • Exhibits169: Evolus Inc. - Key offerings
  • Exhibits170: SWOT
  • Exhibits171: FASTOX Pharma - Overview
  • Exhibits172: FASTOX Pharma - Product / Service
  • Exhibits173: FASTOX Pharma - Key offerings
  • Exhibits174: SWOT
  • Exhibits175: Galderma SA - Overview
  • Exhibits176: Galderma SA - Product / Service
  • Exhibits177: Galderma SA - Key offerings
  • Exhibits178: SWOT
  • Exhibits179: Hugel Inc. - Overview
  • Exhibits180: Hugel Inc. - Product / Service
  • Exhibits181: Hugel Inc. - Key offerings
  • Exhibits182: SWOT
  • Exhibits183: Huons Global - Overview
  • Exhibits184: Huons Global - Product / Service
  • Exhibits185: Huons Global - Key offerings
  • Exhibits186: SWOT
  • Exhibits187: Ipsen Pharma - Overview
  • Exhibits188: Ipsen Pharma - Business segments
  • Exhibits189: Ipsen Pharma - Key offerings
  • Exhibits190: Ipsen Pharma - Segment focus
  • Exhibits191: SWOT
  • Exhibits192: Medytox - Overview
  • Exhibits193: Medytox - Product / Service
  • Exhibits194: Medytox - Key offerings
  • Exhibits195: SWOT
  • Exhibits196: Merz Pharma GmbH and Co. KGaA - Overview
  • Exhibits197: Merz Pharma GmbH and Co. KGaA - Product / Service
  • Exhibits198: Merz Pharma GmbH and Co. KGaA - Key offerings
  • Exhibits199: SWOT
  • Exhibits200: NEXUS LIFECARE PVT. LTD. - Overview
  • Exhibits201: NEXUS LIFECARE PVT. LTD. - Product / Service
  • Exhibits202: NEXUS LIFECARE PVT. LTD. - Key offerings
  • Exhibits203: SWOT
  • Exhibits204: Object Pharma Inc. - Overview
  • Exhibits205: Object Pharma Inc. - Product / Service
  • Exhibits206: Object Pharma Inc. - Key offerings
  • Exhibits207: SWOT
  • Exhibits208: Revance Therapeutics Inc. - Overview
  • Exhibits209: Revance Therapeutics Inc. - Product / Service
  • Exhibits210: Revance Therapeutics Inc. - Key offerings
  • Exhibits211: SWOT
  • Exhibits212: SciVision Biotech Inc. - Overview
  • Exhibits213: SciVision Biotech Inc. - Product / Service
  • Exhibits214: SciVision Biotech Inc. - Key offerings
  • Exhibits215: SWOT
  • Exhibits216: Inclusions checklist
  • Exhibits217: Exclusions checklist
  • Exhibits218: Currency conversion rates for US$
  • Exhibits219: Research methodology
  • Exhibits220: Information sources
  • Exhibits221: Data validation
  • Exhibits222: Validation techniques employed for market sizing
  • Exhibits223: Data synthesis
  • Exhibits224: 360 degree market analysis
  • Exhibits225: List of abbreviations